Wagstaff J - Search Results

1

Hypotension induced by interleukin-3 in patients on angiotensin-converting enzyme inhibitors.

Dercksen MW, Hoekman K, Visser JJ, ten Bokkel Huinink WW, Pinedo HM, Wagstaff J. Dercksen MW, et al. Among authors: wagstaff j. Lancet. 1995 Feb 18;345(8947):448. doi: 10.1016/s0140-6736(95)90426-3. Lancet. 1995. PMID: 7853962 No abstract available.

2

Reversible thyroid dysfunction during treatment with GM-CSF.

Hoekman K, von Blomberg-van der Flier BM, Wagstaff J, Drexhage HA, Pinedo HM. Hoekman K, et al. Among authors: wagstaff j. Lancet. 1991 Aug 31;338(8766):541-2. doi: 10.1016/0140-6736(91)91103-2. Lancet. 1991. PMID: 1678803

3

Effects of interleukin-3 on myelosuppression induced by chemotherapy for ovarian cancer and small cell undifferentiated tumours.

Dercksen MW, Hoekman K, ten Bokkel Huinink WW, Rankin EM, Dubbelman R, van Tinteren H, Wagstaff J, Pinedo HM. Dercksen MW, et al. Among authors: wagstaff j. Br J Cancer. 1993 Nov;68(5):996-1003. doi: 10.1038/bjc.1993.468. Br J Cancer. 1993. PMID: 7692922 Free PMC article.

4

Swelling of metastatic tumors with high-dose interleukin therapy.

Goey SH, Voerman HJ, Strack van Schijndel RJ, van der Hoeven JJ, Wagstaff J, Thijs LG, Pinedo HM. Goey SH, et al. Among authors: wagstaff j. N Engl J Med. 1988 Mar 10;318(10):643-4. doi: 10.1056/NEJM198803103181017. N Engl J Med. 1988. PMID: 3257812 No abstract available.

5

[The application of hematopoietic growth factors in oncology].

Hoekman K, Wagstaff J, Ossenkoppele GJ, Pinedo HM. Hoekman K, et al. Among authors: wagstaff j. Ned Tijdschr Geneeskd. 1991 Mar 9;135(10):409-14. Ned Tijdschr Geneeskd. 1991. PMID: 2020312 Review. Dutch. No abstract available.

6

Renal cell carcinoma and interleukin-2: a review.

Wagstaff J, Baars JW, Wolbink GJ, Hoekman K, Eerenberg-Belmer AJ, Hack CE. Wagstaff J, et al. Eur J Cancer. 1995;31A(3):401-8. doi: 10.1016/0959-8049(94)00494-p. Eur J Cancer. 1995. PMID: 7540404 Review. No abstract available.

7

Angioneurotic oedema and urticaria during therapy with interleukin-2 (IL-2).

Baars JW, Wagstaff J, Hack CE, Wolbink GJ, Eerenberg-Belmer AJ, Pinedo HM. Baars JW, et al. Among authors: wagstaff j. Ann Oncol. 1992 Mar;3(3):243-4. doi: 10.1093/oxfordjournals.annonc.a058162. Ann Oncol. 1992. PMID: 1586626 Free article. No abstract available.

8

Lobular panniculitis after subcutaneous administration of interleukin-2 (IL-2), and its exacerbation during intravenous therapy with IL-2.

Baars JW, Coenen JL, Wagstaff J, van der Valk P, Pinedo HM. Baars JW, et al. Among authors: wagstaff j. Br J Cancer. 1992 Oct;66(4):698-9. doi: 10.1038/bjc.1992.340. Br J Cancer. 1992. PMID: 1419609 Free PMC article.

9

Effects of recombinant human granulocyte-macrophage colony-stimulating factor on myelosuppression induced by multiple cycles of high-dose chemotherapy in patients with advanced breast cancer.

Hoekman K, Wagstaff J, van Groeningen CJ, Vermorken JB, Boven E, Pinedo HM. Hoekman K, et al. Among authors: wagstaff j. J Natl Cancer Inst. 1991 Nov 6;83(21):1546-53. doi: 10.1093/jnci/83.21.1546. J Natl Cancer Inst. 1991. PMID: 1960751 Clinical Trial.

10

Continuous infusion or subcutaneous injection of granulocyte-macrophage colony-stimulating factor: increased efficacy and reduced toxicity when given subcutaneously.

Honkoop AH, Hoekman K, Wagstaff J, van Groeningen CJ, Vermorken JB, Boven E, Pinedo HM. Honkoop AH, et al. Among authors: wagstaff j. Br J Cancer. 1996 Oct;74(7):1132-6. doi: 10.1038/bjc.1996.502. Br J Cancer. 1996. PMID: 8855987 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

299 results

Search Page